Aster DM Healthcare Limited

Aster DM Healthcare Limited

Aster DM Healthcare Limited has received a disclosure under SEBI Takeover Regulations from BCP Asia II Topco IV Pte ltd regarding an acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has changed its name to Aster DM Quality Care Limited, effective from July 3, 2026, following a scheme of amalgamation with Quality Care India Limited.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange about updated outcome of the Board Meeting held on Wednesday, 1 July 2026. The Board approved the appointment of five new directors and the resignation of four directors. The company has also re-constituted its committees and approved the revised list of senior management personnel.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has successfully completed the merger with Quality Care India Limited, creating a stronger platform with a shared purpose of expanding access to world-class healthcare across India.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange about change in Management, with the Board approving the appointment of 6 new directors and the resignation of 4 directors, including the Chief Investor Relations and M&A Officer.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has announced changes in its Board of Directors, including the appointment of five new directors and the resignation of four directors. The new directors include Mr. Varun Khanna as Managing Director & Group Chief Executive Officer, Mr. Neeraj Jain, Mr. Kewal Handa, Mr. V K Mathews, and Ms. Ayshwarya Vikram as Independent Directors, and Mr. Ganesh Mani as a Non-Executive Director. The company has also reconstituted its committees and made changes to its senior management personnel.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange regarding the contact details of Key Managerial Personnel (KMP) for determining materiality of an event or information, as per Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has announced changes in its Board of Directors, Senior Management Personnel, and Committees following the implementation of the Scheme of Amalgamation. The company has appointed five new directors, including Managing Director & Group Chief Executive Officer Varun Khanna, and Independent Directors Neeraj Jain, Kewal Handa, V K Mathews, and Ayshwarya Vikram. Additionally, the company has reconstituted its Committees and made changes to its Senior Management Personnel.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, with the Scheme becoming effective from 1 July 2026.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange regarding the Effective Date of the Scheme, Change in Promoter category, and Amended MoA & AOA of the Company pursuant to the Scheme of Amalgamation.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has acquired 3,57,143 Optionally Convertible Redeemable Preference Shares in Alfaone Medicals Private Limited, an associate company, at Rs. 700/- each, including a security premium of Rs. 690/- each.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange that the Record Date for determining the entitlement of equity shareholders of QCIL for allotment of shares in Aster DM Healthcare Limited has been fixed as 09-Jul-2026.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on June 25, 2026, noting of NCLT Order and Fixation of Record Date pursuant to the Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has informed the Exchange about receipt of certified true copy of the order of NCLT sanctioning Scheme of Amalgamation between Quality Care India Limited and Aster DM Healthcare Limited.

Aster DM Healthcare Limited

Aster DM Healthcare Limited announced that its subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, has allotted 12,00,000 Series A and 34,30,000 Series B Compulsorily Convertible Preference Shares (CCPS) to identified investors via a preferential private placement. The subsidiary is also seeking additional investment for further capital. Aster DM Healthcare confirmed its shareholding in the Sarjapur entity will remain above 75% on an as-if converted basis, even after these allotments and future investments.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has announced that the National Company Law Tribunal (NCLT), Hyderabad Bench, has officially approved its Scheme of Amalgamation. This scheme involves the merger of Quality Care India Limited (the Transferor Company) with Aster DM Healthcare Limited (the Transferee Company). The NCLT's sanction marks a crucial regulatory milestone, allowing the proposed amalgamation to proceed. For investors, this signifies the successful clearance of a major hurdle in the company's corporate restructuring, potentially leading to enhanced operational synergies and strategic consolidation.

Aster DM Healthcare Limited

Aster DM Healthcare Limited has acquired 4,50,89,995 equity shares in its wholly owned subsidiary, Aster DM Super-Specialty Hospital (Sarjapur) Private Limited, through a rights issue.